Brocoter 66.65 mg/1.5 mg Syrup
By Brocoter
Rx
100ml Syrup in a Bottle

Composition
Guaifenesin(66.65mg) + Terbutaline(1.5mg)

Manufacturer - Dexter Labratories

Expires on or after
October, 2025

liver
Brocoter 66.65 mg/1.5 mg Syrup should be used carefully in individuals with liver disease. It may be necessary to adjust the dosage of Brocoter 66.65 mg/1.5 mg Syrup in such cases. It is essential to consult your doctor before using this syrup if you have liver issues. There is limited information regarding the safety of Brocoter 66.65 mg/1.5 mg Syrup in patients with liver problems.

kidney
Use Brocoter 66.65 mg/1.5 mg Syrup carefully if you have kidney disease. Your doctor may need to adjust the dosage. Consult your doctor for guidance.

alcohol
Consult your doctor when consuming alcohol with Brocoter 66.65 mg/1.5 mg Syrup.

driving
Driving is generally not affected when taking Brocoter 66.65 mg/1.5 mg Syrup.

pregnancy
Brocoter 66.65 mg/1.5 mg Syrup may not be safe during pregnancy. Animal studies suggest potential harm to the developing baby. Your doctor will assess the risks versus benefits before prescribing. It is advised to consult your doctor before using Brocoter 66.65 mg/1.5 mg Syrup.

breastfeeding
Brocoter 66.65 mg/1.5 mg Syrup is considered safe for use during breastfeeding based on limited human data indicating no significant risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹49.22
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024